WallStreetZenWallStreetZen

NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Stock Ownership - Who owns Coeptis Therapeutics Holdings?

Insider buying vs selling

Have Coeptis Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Tara DesilvaDirector2024-01-121,800$0.58
$1.04kBuy
Tara DesilvaDirector2024-01-12466$0.56
$260.96Buy
Brian CogleyChief Financial Officer2024-01-105,000$0.67
$3.35kBuy
David MehalickCEO and President2024-01-086,000$0.67
$4.02kBuy
David MehalickCEO and President2024-01-0814,004$0.66
$9.24kBuy
Daniel Alexander YeraceVP of Operations2024-01-0510,850$0.69
$7.49kBuy
Christopher P. CochranDirector2024-01-057,000$0.77
$5.39kBuy
David MehalickCEO and President2024-01-055,050$0.69
$3.48kBuy
Gene SalkindDirector2024-01-0511,600$0.69
$8.00kBuy
Gene SalkindDirector2023-08-294,006$1.01
$4.05kBuy

1 of 2

COEP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COEP insiders and whales buy or sell their stock.

COEP Shareholders

What type of owners hold Coeptis Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC9.75%3,520,000$1.18MInstitution
Chris Calise9.25%3,339,897$1.12MInsider
David Mehalick7.71%2,782,615$932.18kInsider
Robert Striar5.20%1,875,000$628.13kInsider
Bull Horn Holdings Sponsor LLC5.20%1,875,000$628.13kInsider
Daniel Alexander Yerace2.97%1,071,455$358.94kInsider
Christine Elise Sheehy2.80%1,010,605$338.55kInsider
Barclays PLC2.72%979,975$328.29kInsider
Glazer Capital LLC2.67%964,422$323.08kInsider
Creative Planning1.79%645,104$216.11kInstitution

1 of 3

COEP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COEP13.11%41.01%Net Buying
KPRX1.15%47.24%
BNOX0.07%0.00%
PBM3.69%66.53%Net Selling
MNPR1.40%98.60%Net SellingNet Selling

Coeptis Therapeutics Holdings Stock Ownership FAQ

Who owns Coeptis Therapeutics Holdings?

Coeptis Therapeutics Holdings (NASDAQ: COEP) is owned by 13.11% institutional shareholders, 41.01% Coeptis Therapeutics Holdings insiders, and 45.87% retail investors. Chris Calise is the largest individual Coeptis Therapeutics Holdings shareholder, owning 3.34M shares representing 9.25% of the company. Chris Calise's Coeptis Therapeutics Holdings shares are currently valued at $1.12M.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.